Literature DB >> 12468829

Anti-tumour necrosis factor therapy associated with cutaneous vasculitis.

P A Livermore, K J Murray.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12468829     DOI: 10.1093/rheumatology/41.12.1450

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


× No keyword cloud information.
  3 in total

1.  Tumour necrosis factor alpha blockade and the risk of vasculitis.

Authors:  M De Bandt; B Saint-Marcoux
Journal:  Ann Rheum Dis       Date:  2006-11       Impact factor: 19.103

Review 2.  The safety profile of biologic therapies for juvenile idiopathic arthritis.

Authors:  Philip J Hashkes; Yosef Uziel; Ronald M Laxer
Journal:  Nat Rev Rheumatol       Date:  2010-08-31       Impact factor: 20.543

3.  Digital vasculitis: a late complication of anti-tumour necrosis factor alpha therapy.

Authors:  Pamela Mangat; Samuel Whittle; Les Cleland; Vidya Limaye
Journal:  Clin Rheumatol       Date:  2008-09-27       Impact factor: 2.980

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.